Terminated NA INTERVENTIONAL 2-arm NCT01923805

Vitagel Revision Total Knee Arthroplasty

A Prospective Randomized Evaluation of a Collagen/Thrombin Autologous Platelet Hemostatic Agent During Revision Knee Arthroplasty

Sponsor: Stryker Nordic

Conditions Failed Total Knee Arthroplasty

Interventions Vitagel

Updated 9 times since 2017 Last updated: May 5, 2017 Started: Apr 30, 2013 Primary completion: Mar 31, 2014 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Difficulty enrolling patients

A NA clinical study on Failed Total Knee Arthroplasty, this trial is terminated or withdrawn. The trial is conducted by Stryker Nordic and has accumulated 9 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA
Jan 2021 — Dec 2022 [monthly]

Terminated NA

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jul 2017 — Jun 2018 [monthly]

Terminated NA

Status: Unknown Status → Terminated · Phase: PHASE4 → NA
Feb 2017 — Jul 2017 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stryker Nordic
The Cleveland Clinic

Data source: The Cleveland Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States